Prism Medico & Pharmacy Ltd Management Discussions.

Your Directors have pleasure in presenting the Management Discussion and Analysis report for the year ended on 31stMarch 2020.

COVID-19 UPDATE

Currently, the global economic environment is highly unpredictable as the duration and the impact of unprecedented COVID-19 pandemic is difficult to ascertain. Amidst one of the most uncertain environment faced today, our employees are relentlessly working towards providing uninterrupted supply of cattle feed and other supplements.. Your Company is ensuring utmost safety of its employees by following measures such as usage of masks/gloves, regular temperature screening, setting up of disinfectant tunnels, maintaining social distancing, allowing limited workforce and conducting comprehensive factory sanitization. Post the COVID-19 outbreak in mid-March 2020, our operations were disrupted as volumes and sales declined and factories were closed, after the nationwide lockdown announced on March 24, 2020. However, al activities were allowed during lockdown and our factories became operational in at the earliest, after obtaining necessary approvals from local authorities. The demand remains firm and your Company is taking all necessary steps to ensure smooth supply of products along with maintaining safety of employees and business partners.

INDUSTRY STRUCTURE. DEVELOPMENT:

The Company has been established with the object financing. 2018-19 was a year of mixed growth for the domestic economy, which had, over the previous three years witnessed a series of domestic and externalheadwinds.

The industry is showing some improvement as a result of shrinking current account and fiscal deficit and stabilization in the rupee. Going ahead your Directors are expecting better industrial development in the coming years.

SEGMENT-WISE PERFORMANCE:

The Company trades in a single business segment.

OPPORTUNITIES AND OUTLOOK:

The Company is taking maximum efforts to capitalize on business opportunities & further expect a better outlook in the coming years.

Future Outlook

• Enhance accessibility in the regulated genericsbusiness.

• To unlock the true potential of hugeinvestments

• Consolidate its presence in the business by focusing on regulatedmarkets.

• Strategic entry in highly regulated markets.

• Expand relationships with marque clients with additional newproducts.

• Enhance market penetration with existingproducts.

• Increase its operations in emergingmarkets.

• Focus on R & D andwork.

STRENGTH:

The existing management has a strong technical, finance and administrative expertise in various industries and corporate sectors including the business of the Company.

RISKS AND CONCERNS:

While risk is an inherent aspect of any business, the Company being in financing so its primarily exposed to credit risk, liquidity risk, interest rate risk as well as operational risks. We maintain a conservative approach and manage the credit risk through prudent selection of clients, delegation of appropriate lending powers and by stipulating various prudential limits. The identification, measurement, monitoring and management of risks remain a key focus area for the Company. We have in place a proper risk mitigating methods and effective credit operations structure. The Board of Directors of your Company endorses the risk strategy and approves the risk policies.

INFORMATION TECHNOLOGY

Our Company constantly upgrades its technology both in terms of hardware and software. This also helped installing a good management information system for the management to get timely information for decisionmaking.

INTERNAL CONTROL SYSTEM AND THEIR ADEQUACY

The internal control system is looked after by Directors themselves, who also looked after the day to day affairs to ensure compliances of guide lines and policies adhere to the management instructions and policies to ensure improvements in the system. The Internal Audit reports are regularly reviewed by the management. Internal Control measures and systems are established to ensure the correctness of the transactions and safe guarding of the assets. The control systems set on place are checked and further supplemented by MIS which provided for planned expenditure and information on disposal and acquisition of assets. Efforts for continued improvement of internal control system are being consistently made in this regard.

HUMAN RESOURCES VIS-A-VIS INDUSTRIAL RELATIONS:

The Company values and appreciates the dedication and drive with which its employees have contributed towards improved performance during the year under review. The relations with workers and staff are cordial during the year under review. All issues pertaining to staff matters are resolved in harmonious and cordial manner.

CAUTIONARY STATEMENT:

Statements in the Management Discussion and Analysis describing the Companys objectives, projections, estimates and expectations may be forward looking statements within the meaning of applicable securities laws and regulations. Actual results could differ materially from those expressed or implied. Important factors that could make a difference to the Companys operations include economic conditions affecting demand/supply and price conditions in the domestic and overseas markets in which the Company operates changes in the Government regulations, tax laws, and other statutes and other incidentalfactors.

For And On Behalf Of The Board Of Directors For Prism Medico & Pharmacy Limited

Place: Mohali Sudhanshu Srivastav Jimit Jitendra Trivedi
Date:13/08/2020 Director Director
DIN - 08242441 DIN-08585697